Liver Cancer:
Liver Cancer, Symptoms of Liver Cancer and Treatment News.
Ads by Google
-
BOSTON, MA--For the first time, researchers have discovered a special type of molecular regulator called a micro-RNA (miR-124) that could be used someday as a treatment for liver cancer. The same team also found a mechanism in mice that ultimately causes normal liver cells to transform into cancerous ones.
-
A novel treatment for liver cancer that involves electromagnetic fields has shown promise in a phase II study, according to researchers at the University of Alabama at Birmingham (UAB). The unusual treatment was found to shrink liver cancer tumors and did so without affecting normal cells.
-
The anti-inflammatory drug celexicob caused liver cells to self destruct in lab experiments. The drug, marketed as Celebrex, combined with two chemotherapy drugs, destroyed liver cancer cells more quickly than using the only approved chemotherapy drug on the market for liver cancer. The findings, say researchers, would clinicians more treatment options for patients with the disease, pending trials in humans.
-
A study from Columbia Technology Ventures, who were studying combat injury-related depression, has found an alternative to opiates or anti-depressants for chronic pain, the chemical N60.
-
Scientists investigated the behaviour of a new DNA damage repair enzyme called ALC1 (Amplified in Liver Cancer 1) which is found in excessive amounts in half of liver cancers.
-
California researchers found that the nutritional supplement SAMe (S-adenosylmethionine) was successful in preventing the formation of primary liver cancer in rats. Primary liver cancer, also known as hepatocellular carcinoma (HCC) is the third most frequent cause of cancer death in the world.
-
Many of the major newspapers are reporting that Steve Jobs, the chief executive of Apple Inc, received a liver transplant about two months ago. There is no confirmation of the report by either Jobs or Apple.
-
Researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time. The researchers wanted to find agents that might reverse the gene changes associated with invasive liver cancer and perhaps stop liver tumors from spreading in the body.
-
Using tiny chemotherapy-soaked beads to choke off and kill cancerous liver tumors is becoming more successful.
-
Researchers are poised to unlock the genetic secrets stored in hundreds of thousands of cancer biopsy samples that are in long-term storage and previously thought to be useless for modern genetic research.
